Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['ovarian', 'imfinzi', 'lynparza', 'astrazeneca']
asco: astrazeneca imfinzi-lynparza shows benefit in phase iii ovarian cancer study 
BioCalifornia is committed to the growth of life sciences, and commercialization of discoveries to improve human health, the environment, and sustainability.